SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-21-013676
Filing Date
2021-04-21
Accepted
2021-04-21 16:51:02
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A nc10022459x2_defa14a.htm DEFA14A 14676
2 logo_appliedtherapeutics.jpg GRAPHIC 25271
3 nc10022459x2_noticecard1.jpg GRAPHIC 134960
4 nc10022459x2_noticecard2.jpg GRAPHIC 71810
  Complete submission text file 0001140361-21-013676.txt   326617
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38898 | Film No.: 21842242
SIC: 2834 Pharmaceutical Preparations